Neelam V Desai

7PUBLICATIONS
18CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2023
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.

Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen

|May 10, 2023
Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1/2-Mutated Breast Cancers in the High-Risk, Early-Stage Setting.

Neelam V Desai, Antoinette R Tan

|May 10, 2022
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.

Adrienne G Waks, Neelam V Desai, Tianyu Li

|Jan 07, 2022
Q and A: A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer.

Neelam V Desai, Dana Zakalik, Mark R Somerfield

|Sep 07, 2021
Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test.

Nadine Tung, Neelam Desai

|Nov 04, 2020
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.

Neelam V Desai, Siddhartha Yadav, Felipe Batalini

Pageof 2

Frequent Collaborators

4 joint publications

Nadine Tung

1 joint publications

Siddhartha Yadav

1 joint publications

Felipe Batalini

1 joint publications

Dana Zakalik